Prednisolone Addition for Patients With Recent-onset Psychotic Disorder

NCT02949232 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Difficulties with recruitment

Conditions

Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Psychotic Disorder NOS

Interventions

DRUG: Prednisolone
DRUG: Placebo Oral Tablet

Sponsor

UMC Utrecht